Answers are grounded in this paper and cite their sources.
Background Medikinet ® MR and Concerta ® are long-acting methylphenidate formulations used for the treatment of pediatric and adult attention-deficit/hyperactivity disorder (ADHD). The two formulations have shown comparable safety profiles in two head-to-head randomized controlled trials. However, real-world studies comparing the safety profiles of these products are not available. Objective This study aimed to compare the real-world safety of Medikinet ® MR and Concerta ® using register data. Method This population-based cohort study was conducted based on data from Danish registries. The study included patients with continuous long-term (i.e., ≥12 months) exposure to either Medikinet ® MR or Concerta ® between 1995 and 2018. Outcomes included several selected adverse events of interest. A sensitivity analysis was performed, excluding patients exposed to Concerta ® generics. For each outcome, Fisher’s exact test was performed to compare the number of cases between the two groups. Odds ratios (ORs) and 95% confidence intervals were estimated using logistic regression models with patients exposed to Concerta ® as the reference group. Results The study population included 1249 patients exposed to Medikinet ® MR and 2455 patients exposed to Concerta®. No cases of cerebral arteritis or priapism were identified in either cohort. ORs for sudden death and anorexia could not be calculated due to the absence of cases in the Medikinet ® MR cohort. For the remaining outcomes, no statistically significant difference in risk was found between Medikinet ® MR-exposed and Concerta ® -exposed patients. The sensitivity analysis produced results consistent with those obtained in the main analysis. Conclusions The results of this population-based cohort study indicate that Medikinet ® MR and Concerta ® have comparable real-world safety profiles.
No takes yet. Share an insight, caveat, or question.
Ørnberg et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: